These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 30118354)

  • 1. Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases.
    Felice C; Pugliese D; Papparella LG; Pizzolante F; Onori E; Gasbarrini A; Rapaccini GL; Guidi L; Armuzzi A
    Expert Rev Clin Immunol; 2018 Sep; 14(9):751-759. PubMed ID: 30118354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spondyloarthritis and inflammatory bowel disease. Comorbidity and treatment implications.
    Varkas G; Van Praet L; Cypers H; Elewaut D
    Z Rheumatol; 2013 Aug; 72(6):524-9. PubMed ID: 23756592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents.
    Gao X; Wendling D; Botteman MF; Carter JA; Rao S; Cifaldi M
    J Med Econ; 2012; 15(6):1054-63. PubMed ID: 22563743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?
    Mitulescu TC; Trandafir M; Dimăncescu MG; Ciuluvică RC; Popescu V; Predețeanu D; Istrate S; Voinea LM
    Rom J Ophthalmol; 2018; 62(2):114-122. PubMed ID: 30206554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Spondylarthritides].
    Braun J; Sieper J
    Z Rheumatol; 2006 Nov; 65(7):613-31; quiz 632. PubMed ID: 17072572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seronegative spondyloarthropathy-associated inflammatory bowel disease.
    Wang CR; Tsai HW
    World J Gastroenterol; 2023 Jan; 29(3):450-468. PubMed ID: 36688014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on therapeutic management of spondyloarthritis associated with inflammatory bowel disease.
    Ben Nessib D; Ferjani H; Maatallah K; Rahmouni S; Kaffel D; Hamdi W
    Clin Rheumatol; 2020 Dec; 39(12):3543-3553. PubMed ID: 32424656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease.
    Barré A; Colombel JF; Ungaro R
    Aliment Pharmacol Ther; 2018 Apr; 47(7):896-905. PubMed ID: 29430672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases].
    Schüle S; Frey D; Biedermann L; Grueber MM; Zeitz J; Vavricka S; Möller B; Rogler G; Misselwitz B
    Praxis (Bern 1994); 2019 Sep; 108(12):799-806. PubMed ID: 31530124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New evidence on the management of spondyloarthritis.
    Sieper J; Poddubnyy D
    Nat Rev Rheumatol; 2016 May; 12(5):282-95. PubMed ID: 27052489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical Reactions: Anti-Tumor Necrosis Factor Alpha Agents, Ustekinumab, Secukinumab, Ixekizumab, and Others.
    Puig L
    Curr Probl Dermatol; 2018; 53():49-63. PubMed ID: 29131037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in spondyloarthritis except for psoriatic arthritis].
    Juanola Roura X; Zarco Montejo P; Sanz Sanz J; Muñoz Fernández S; Mulero Mendoza J; Linares Ferrando LF; Gratacós Masmitja J; García de Vicuña R; Fernandez Carballido C; Collantes Estevez E; Batlle Gualda E; Ariza Ariza R; Loza Santamaría E
    Reumatol Clin; 2011; 7(2):113-23. PubMed ID: 21794794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.
    Olivieri I; Cantini F; Castiglione F; Felice C; Gionchetti P; Orlando A; Salvarani C; Scarpa R; Vecchi M; Armuzzi A
    Autoimmun Rev; 2014 Aug; 13(8):822-30. PubMed ID: 24726868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current therapeutics for spondyloarthritis.
    Toussirot É
    Expert Opin Pharmacother; 2011 Nov; 12(16):2469-77. PubMed ID: 21988214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Articular manifestations in patients with inflammatory bowel disease treated with vedolizumab.
    Dupré A; Collins M; Nocturne G; Carbonnel F; Mariette X; Seror R
    Rheumatology (Oxford); 2020 Nov; 59(11):3275-3283. PubMed ID: 32259251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatment options and emerging drugs for axial spondyloarthritis: biological and targeted synthetic agents.
    Toussirot E
    Expert Opin Pharmacother; 2017 Feb; 18(3):275-282. PubMed ID: 28099816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring vedolizumab and ustekinumab drug levels in patients with inflammatory bowel disease: hype or hope?
    Alsoud D; Vermeire S; Verstockt B
    Curr Opin Pharmacol; 2020 Dec; 55():17-30. PubMed ID: 33039940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.
    Papamichael K; Cheifetz AS; Melmed GY; Irving PM; Vande Casteele N; Kozuch PL; Raffals LE; Baidoo L; Bressler B; Devlin SM; Jones J; Kaplan GG; Sparrow MP; Velayos FS; Ullman T; Siegel CA
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1655-1668.e3. PubMed ID: 30928454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease.
    Paccou J; Nachury M; Duchemin C; Desreumaux P; Flipo RM; Pariente B
    Joint Bone Spine; 2019 Oct; 86(5):654-656. PubMed ID: 30711690
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological therapy of spondyloarthritis.
    Palazzi C; D'Angelo S; Gilio M; Leccese P; Padula A; Olivieri I
    Expert Opin Pharmacother; 2015; 16(10):1495-504. PubMed ID: 26073668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.